REIN THERAPEUTICS, INC. (RNTX) Operating cash flow 2016–2025
REIN THERAPEUTICS, INC. (RNTX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$19.4MFY2025 · since FY2016: -$15.0M → -$19.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.4M | +13.1% |
| FY2024 | -$22.3M | -12.5% |
| FY2023 | -$19.8M | +20.3% |
| FY2022 | -$24.9M | -4.7% |
| FY2021 | -$23.8M | -16.0% |
| FY2020 | -$20.5M | +22.7% |
| FY2019 | -$26.5M | +5.2% |
| FY2018 | -$27.9M | -36.0% |
| FY2017 | -$20.5M | -36.7% |
| FY2016 | -$15.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice